PLA2-responsive and SPIO-loaded phospholipid micelles
Qiang Gao, a,b Lesan Yan, a Michael Chiorazzo, c E. James Delikatny, c Andrew Tsourkas a and Zhiliang Cheng *a A PLA 2 -responsive and superparamagnetic iron oxide (SPIO) nanoparticle-loaded phospholipid micelle was developed. The release of phospholipid-conjugated dye from these micelles was triggered due to phospholipid degradation by phospholipase A 2 . High relaxivity of the encapsulated SPIO could enable non-invasive magnetic resonance imaging.
Phospholipase A 2 (PLA 2 ) specifically recognizes and catalytically hydrolyzes phospholipids at the sn-2 position to form fatty acid and lysophospholipid products. Elevated levels of PLA 2 have been associated with a number of diseases and pathologies including atherosclerosis, 1 pancreatitis, 2 acute sepsis, 3 and cancer. 4 For example, in prostate cancer PLA 2 levels have been found to be up to 22-fold higher than physiological levels. [5] [6] [7] Thus it has been suggested that PLA 2 enzymes can serve as a novel diagnostic and therapeutic target for certain diseases. To date, a substantial amount of effort has been made in developing novel drug delivery system that seeks to concentrate the therapeutic agents in the desired sites while reducing the relative concentration in healthy tissues. One promising approach involves the use of stimulus-responsive nanoparticles that require endogenous or external stimuli to trigger drug release. The ability to limit drug release to a particular location can lead to lower offtarget toxicity and improve the therapeutic index. 8 While many types of stimuli including pH, temperature, light, ultrasound and proteolysis have been explored, 9-11 few studies have utilized PLA 2 to trigger drug release.
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Successful nanoparticle-based drug delivery is a very complicated process that involves the distribution, metabolism and excretion of the drug. The ability to non-invasively track nanoparticles following their administration is therefore expected to be highly valuable. A promising strategy for achieving this goal is to develop multifunctional nanoparticles that combine therapeutic and diagnostic functions within a single nanoformulation, i.e. "theranostic" agents. 13 It is expected that theranostic agents could provide important insight into localization of the drug and allow pathological processes to be monitored longitudinally.
Currently, a wide range of nanoparticle platforms including dendrimers, 14 liposomes, 15 polymersomes, 16 micelles, 17 emulsions, 18 and silica nanoparticles, 19 have been tested as platforms for drug nanocarriers. Among the many nanoparticulate systems, phospholipid-based micelles are particularly attractive due to the recognized and tested biocompatibility of many phospholipids as well as their controlled size, ability to solubilize hydrophobic drugs/imaging agents, and favorable pharmacokinetics. 20, 21 Herein, we report the design and testing of a PLA 2 -responsive and superparamagnetic iron oxide (SPIO) nanoparticle-loaded phospholipid micelle (Scheme 1). It was expected that PLA 2 -responsive phospholipid micelles loaded with SPIO nanoparticles could provide drug release specifically in response to PLA 2 activity, and also enable non-invasive magnetic resonance (MR) imaging.
Scheme 1 Schematic diagram of PLA 2 -responsive and SPIO-loaded phospholipid micelle.
Oleic acid-stabilized hydrophobic SPIONs were synthesized with mean diameters of approximately 13 nm. Transmission electron microscopy (TEM) images revealed a narrow distribution of spherical SPIOs (Supp. Figure S1A ). Using an oil-in-water emulsion method, 22 Please do not adjust margins
Please do not adjust margins hydrogenated soy phosphatidylcholine (HSPC) and the fluorescent lipid 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (NBD-PC). The fluorophore NBD was attached to the sn-2 position of the phospholipid with a spacer (C6) between NBD and the lipid backbone, which was used to mimic a PLA 2 -responsvie prodrug. It was hypothesized that PLA 2 could specifically recognize and catalytically hydrolyze the sn-2 acyl bond of NBD-PC, resulting in the release of NBD. SPIO-loaded phospholipid micelles possessed a mean hydrodynamic diameter of 100 nm and low polydispersity (PDI <0.25) as determined by dynamic light scattering (DLS; Figure  1A ). Due to the amphipathic properties of phospholipid molecules, these SPIO-micelles were highly soluble in aqueous solutions. TEM further confirmed the encapsulation of the SPIO within the micelles (Supp. Figure S1B) . The SPIO-micelles observed by TEM were approximately spherical in shape with tightly packed clusters of SPIO encapsulated within the hydrophobic core. To assess the paramagnetic properties of the SPIO-loaded phospholipid micelles, the amount of iron (Fe) within the sample was determined by inductively coupled plasma optical emission spectroscopy (ICP-OES). The transverse r2 relaxivity was then calculated as the slope of the curves 1/T2 vs. Fe concentration, as shown in Figure 1B . T2 (transverse relaxation times) were determined using a Bruker mq60 MR relaxometer operating at 1.41 T (60 MHz) and at 40 °C. It was found that SPIO-loaded micelles had an r2 of 90 mM -1 s -1
. It should be noted that since tens of hydrophobic SPIO nanoparticles can be encapsulated within each 100 nm micelle, the SPIO-loaded micelles can generate a relaxivity that is amplified by a factor of 10 or more on a per particle basis, compared to a single SPIO nanoparticle. Therefore, it is expected that these agents are sufficiently sensitive for noninvasive MR imaging and tracking. As seen in Figure 2A , dissolution of the SPIO-micelles with surfactant Triton X-100 led to a significant increase in fluorescence. These findings imply that the NBD is highly quenched within the SPIO-micelle. There are two factors that likely contribute to the highly quenched state of NBD, self-quenching due to the high loading density (i.e. 10mol%) of NBD-PC within the micelles and quenching through interactions with the encapsulated SPIO nanoparticles. To explore the impact of self-quenching alone on NBP fluorescence, phospholipid micelles doped with 10mol% NBP-PC were prepared in the absence of SPIO nanoparticles and fluorescence was recorded before and after the addition of Triton X-100. It was found that in the absence of SPIO nanoparticles, fluorophore-fluorophore interactions alone led to more than 90% quenching of NBP fluorescence. Therefore, it is likely that this was the primary mechanism responsible for a low NBP signal in the micelles (Supp. Figure S2) . The presence of SPIO nanoparticles further reduced fluorescence of the micelles. As a result, dissolution of the SPIO-micelles led to a ~30-fold increase in NBP fluorescence compared with ~15-fold for the empty micelles ( Figure 2B) . Because of the efficient quenching of NBP fluorescence in the SPIO-micelles, it was expected that the PLA 2 -triggered release of NBD could be monitored fluorometrically. When SPIO-loaded micelles were incubated in 10 mM HEPES buffer, little to no change in fluorescence was observed over a 24h time period. However, a significant increase in fluorescence intensity was observed immediately upon the addition of PLA 2 ( Figure 3A) . It should be noted that secreted PLA2 was used in this study. The PLA 2 -induced change in fluorescence was presumable due to the release of NBD into the surrounding bulk solution upon the hydrolysis of the phospholipid membrane by PLA 2 . The released NBD led to fluorescence dequenching, resulting in a higher fluorescence intensity compared with fluorescence intensity from the SPIO-loaded-micelles. Furthermore, this change was time and concentration dependent. The intensity of fluorescence increased with increasing PLA 2 concentration in the range of 0 to 300 unit/L. In addition, the rate of increase in fluorescence increased with PLA 2 concentration.
To further confirm that the measured changes in fluorescence signal were specifically caused by PLA 2 -mediated mechanisms, experiments were also performed under two different conditions. First, SPIO-loaded micelles were incubated with PLA 2 in the media containing the calcium chelator EGTA (ethylene glycol tetraacetic acid). As expected, no change in fluorescence was observed since the activity of this PLA 2 enzyme is calcium-dependent ( Figure 3B ). 23, 24 Second, studies were performed by incubating the SPIO-micelles with both PLA 2 and increasing concentrations of the enzyme inhibitor LY311727. Under these conditions, LY311727 inhibited PLA 2 activity and led to a reduction in the extent of fluorescence activation in a concentration dependent manner ( Figure 3C ). These results confirm that the observed changes in fluorescence were PLA 2 -specific.
In this work we developed PLA 2 -responsive SPIO-loaded phospholipid micelles. The release of phospholipid-conjugated dye from these micelles was triggered due to phospholipid hydrolysis by PLA 2 . Furthermore, many small hydrophobic SPIO nanoparticles were encapsulated within the micelle core, which could serve as highly efficient MR contrast agent for in vivo imaging. As a consequence, future work will be aimed at developing PLA 2 -responsive multifunctional micelles containing therapeutic (i.e. phospholipid-conjugated prodrug), imaging (i.e. SPIO), and targeting agents. M. For all studies, the final concentration (Fe) of SPIO-loaded micelles and Ca 2+ in the HEPES buffer (10 mM, pH 7.4) was 16.3 g/mL and 2 mM, respectively. For B&C, the final concentration of PLA 2 in the buffer was 60 U/L. The black arrow indicated the time for the adding PLA 2 . All experiments were performed at room temperature.
